The goal of the proposed research is to elucidate the molecular pathogenetic mechanism of maternally inherited aminoglycoside induced hearing impairment. Aminoglycoside ototoxicity is a major clinical problem. In the United States, almost 4 million courses of aminoglycoside antibiotics are administrated annually for infections. It is estimated that between 2 to 5 percent of patients treated with these drugs develop significant hearing loss. In the developing countries, the problem of ototoxic side effects is more acute due to the widespread use of these drugs. Aminoglycoside ototoxicity is a complex multifactorial disorder resulting from interaction between genetic and environmental factors. The aminoglycoside hypersensitivity is often maternally transmitted. Recently, the A1 555G mutation in the mitochondrial 12S rRNA gene has been identified as an inherited mutation that predisposes to amingolycoside ototoxicity. This mutation accounts for a significant portion of patients with aminoglycoside ototoxicity. However, numerous important questions remain unanswered regarding the molecular and biochemical basis for genetic susceptibility to aminoglycoside ototoxicity.We hypothesize that human mitochondrial 12S rRNA, particularly that canying the A1555G mutation, is the main target of aminoglycosides and that these drugs exert their detrimental effects in the cochlea through an alternation of mitochondrial protein synthesis. We also hypothesize that there are additional mtDNA mutations associated with aminoglycoside ototoxicity. To test these hypotheses, we propose the specific aims as follows: 1) Examination of the binding of these drugs to the decoding site of mitochondrial 12S rRNA. 2). Examination of the mitochondrial specificity and dosage effect on these antibiotics by analysis of growth properties and rate of mitochondrial protein synthesis in A1555G mutation disease cell model. 3) Identification and evaluation of additional mtDNA mutations associated with aminoglycoside ototoxicity by a systemic and extended screening of a large Chinese clinical patient population with aminoglycoside ototoxicity.Success of this project will provide new insight into the pathogenic mechanisms of aminglycoside-associated ototoxicity, which in turns provide valuable new information and technology for the diagnosis and prevention of this disorder. The data from this study will help to predict which individuals are at risk for ototoxicity, improve the safety of clinical implications for the aminoglycoside-antibiotc therapy, and decrease the incidence of deafness. The ultimate goal of this study is to develop the aminoglycoside analogs with less toxicity and to provide aminoglycoside treatment strategies that prevent irreversible cochlear damage.

Agency
National Institute of Health (NIH)
Institute
National Institute on Deafness and Other Communication Disorders (NIDCD)
Type
Research Project (R01)
Project #
3R01DC005230-02S1
Application #
6891501
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Watson, Bracie
Project Start
2002-09-15
Project End
2007-08-31
Budget Start
2004-06-01
Budget End
2004-08-31
Support Year
2
Fiscal Year
2004
Total Cost
$16,688
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Meng, Feilong; Cang, Xiaohui; Peng, Yanyan et al. (2017) Biochemical Evidence for a Nuclear Modifier Allele (A10S) in TRMU (Methylaminomethyl-2-thiouridylate-methyltransferase) Related to Mitochondrial tRNA Modification in the Phenotypic Manifestation of Deafness-associated 12S rRNA Mutation. J Biol Chem 292:2881-2892
Qian, Yaping; Zhou, Xiangtian; Liang, Min et al. (2011) The altered activity of complex III may contribute to the high penetrance of Leber's hereditary optic neuropathy in a Chinese family carrying the ND4 G11778A mutation. Mitochondrion 11:871-7
Yan, Xukun; Wang, Xinjian; Wang, Zhengmin et al. (2011) Maternally transmitted late-onset non-syndromic deafness is associated with the novel heteroplasmic T12201C mutation in the mitochondrial tRNAHis gene. J Med Genet 48:682-90
Shen, Zhisen; Zheng, Jing; Chen, Bobei et al. (2011) Frequency and spectrum of mitochondrial 12S rRNA variants in 440 Han Chinese hearing impaired pediatric subjects from two otology clinics. J Transl Med 9:4
Liu, Xiao-Ling; Zhou, Xiangtian; Zhou, Jian et al. (2011) Leber's hereditary optic neuropathy is associated with the T12338C mutation in mitochondrial ND5 gene in six Han Chinese families. Ophthalmology 118:978-85
Lu, Zhongqiu; Chen, Hong; Meng, Yanzi et al. (2011) The tRNAMet 4435A>G mutation in the mitochondrial haplogroup G2a1 is responsible for maternally inherited hypertension in a Chinese pedigree. Eur J Hum Genet 19:1181-6
Wang, Shiwen; Li, Ronghua; Fettermann, Andrea et al. (2011) Maternally inherited essential hypertension is associated with the novel 4263A>G mutation in the mitochondrial tRNAIle gene in a large Han Chinese family. Circ Res 108:862-70
Guan, Min-Xin (2011) Mitochondrial 12S rRNA mutations associated with aminoglycoside ototoxicity. Mitochondrion 11:237-45
Tang, Xiaowen; Li, Ronghua; Zheng, Jing et al. (2010) Maternally inherited hearing loss is associated with the novel mitochondrial tRNA Ser(UCN) 7505T>C mutation in a Han Chinese family. Mol Genet Metab 100:57-64
Wang, Xinjian; Yan, Qingfeng; Guan, Min-Xin (2010) Combination of the loss of cmnm5U34 with the lack of s2U34 modifications of tRNALys, tRNAGlu, and tRNAGln altered mitochondrial biogenesis and respiration. J Mol Biol 395:1038-48

Showing the most recent 10 out of 73 publications